Also in this month's issue is an update on Target 2035 from @CherylArrowsmi1, Stefan Knapp and colleagues covering the efforts of the EUbOPEN project which is contributing to the goals of #Target2035💡 Read the #OpenAccess article here⬇
https://t.co/tYFpV03cQm
The AIRCHECK Workshop isn't just another conference! It is an exclusive opportunity to learn, experiment, and get ahead of the curve in ML/AI-driven hit discovery.
Register now: https://t.co/SPvAASEo5T
We are uniting experts in ML, computational chemistry, and drug discovery to get hands-on experience with AIRCHECK. Co-developed by SGC and @UHN, AIRCHECK is an open data platform designed to enhance predictive models in drug discovery.
Register here: https://t.co/SPvAASEo5T
We are uniting experts in ML, computational chemistry, and drug discovery to get hands-on experience with AIRCHECK. Co-developed by SGC and @UHN, AIRCHECK is an open data platform designed to enhance predictive models in drug discovery.
Register here: https://t.co/SPvAASEo5T
@mattschap discusses how SGC will emerge as a leading source of open-science protein-ligand data and shares his vision for building stronger connections between data scientists and drug discovery experimentalists at the @UofT through the newly launched CrossTALK Bootcamp.
Data science is driving breakthroughs in countless areas but a lack of availability of experimental training data has limited its impact on drug discovery.
Learn about the "Galvanizing Data Science Applications in Early Stage Drug Discovery" project:
🔗https://t.co/76fZkWcJD8
A rigorous study of UPS tool compounds for #degrader evaluation is published by Stefan Knapp @thesgconline in ACS Chemical Biology! They determine the appropriate doses of UPS pathway inhibitors that robustly rescue degradation without displaying off-target activity and toxicity.
Researchers at @thesgconline and The Neuro, along with scientists from 11 major antibody manufacturers, have developed and standardized an #OpenScience platform to characterize research antibodies.
@YCharOS1 aims to tackle a critical challenge in biomedical research reproducibility.
🧪 https://t.co/kMKJ6q7DAp
We co-hosted " @target2035 – A Public-Private Partnership to Accelerate Hit-Finding" along with @ucl and @pfizer. 50 leaders from the pharmaceutical industry, academia, and funding organizations discussed how AI and ML can transform drug discovery.
https://t.co/3Ak9LmngoI
#MAINFRAME is launching! This international, #OpenScience Network brings #MachineLearning & #compchem scientists together to create open-source algorithms & benchmarks for tackling real-world challenges in #DrugDiscovery. Join us: https://t.co/xOsrQ1BFdq
We just launched #MAINFRAME! This international, #OpenScience Network brings #MachineLearning & #compchem scientists together to create open-source algorithms & benchmarks for tackling real-world challenges in #DrugDiscovery.
Join us: https://t.co/oAcLGeaK3d
Supported by @UofTDSI, a program led by @mattschap
will provide trainees with the skills necessary to interpret complex experimental data and drive breakthroughs in drug discovery. Registration for the first 9-week bootcamp is now open.
https://t.co/HAA6Rse5rj
New episode for our Target 2035 Podcast Series 🎧
@MilkaKostic talks with @aledmedwards to unpack his journey from a traditional research scientist to a passionate open science advocate.
Listen here: https://t.co/JUI5VWMQ79
A summary of the efforts of @EUbOPEN, a public-private partnership dedicated to create, distribute and annotate the largest openly available set of high-quality chemical modulators for human proteins.
https://t.co/Owd7bmHF7I
We have joined the Bluesky community! Follow us to stay updated on our latest research, collaborations, and efforts to shape the future of drug discovery.
https://t.co/4wAhd4Rsna
How does EZH2 inhibition make atypical teratoid rhabdoid tumor cells vulnerable to therapy?
A collaborative study using UNC1999, a high-quality chemical probe developed through a collaboration between the SGC @UNCPharmacy.
https://t.co/oC6b3G3Wk7
We report four DCAF1-based PROTACs with endogenous and exogenous WDR5 degradation effects and high-resolution crystal structures of the ternary complexes of DCAF1-PROTAC-WDR5.
https://t.co/VnyJoyl23V
#PROTACs#DCAF1#WDR#DrugDiscovery#OpenScience
A comprehensive study that offers validated ligands for future autophagosome tethering compound (ATTEC) development and advances targeted protein degradation strategies.
https://t.co/T6lXyRrexb
A 2024 update on @Chemical_probes highlights a significant expansion in the number of chemical probes and human protein targets, along with major improvements in expert review processes and user engagement.
https://t.co/YfTclLB9qI
A fully open framework for DEL-ML hit discovery. We replace explicit DEL compound structures with ML-ready chemical fingerprints, enabling the broad scientific community to advance DEL-ML models and refine discovery methods. All data available on AIRCHECK.
https://t.co/fg3lyssOpf
A well anticipated overview highlighting the first CACHE challenge, which brought together 23 research teams from 10 countries to collectively predict 1,955 compounds targeting LRRK2-a protein linked to #ParkinsonsDisease.
https://t.co/5P4SAMcmOy